Fibromuscular dysplasia

Changed by Yuranga Weerakkody, 13 Apr 2022

Updates to Article Attributes

Body was changed:

Fibromuscular dysplasia (FMD) is a heterogeneous group of vascular lesions characterised by an idiopathic, non-inflammatory, and non-atherosclerotic angiopathy of small and medium-sized arteries.

Epidemiology

The prevalence is unknown 7. It is most common in young women with a female to male ratio of 3:1, and is typically diagnosed between the ages of 30 and 50 4.

Clinical presentation

Fibromuscular dysplasia is frequently asymptomatic. Symptomatic patients commonly present with:

Pathology

The exact cause is not well known. The underlying pathology is fibrous or fibromuscular thickening of the arterial wall. Any layer of the vessel wall may be affected: intima, media or adventitia. There is absence of inflammatory cells 1-4,7.

Classification 

Fibromuscular dysplasia is classified into five categories according to the vessel wall layer affected:

  • intima: 5% 
  • media: 90-95% 
    • medial dysplasia (70%, commonest type)
    • perimedial (subadventitial) fibroplasia (15-20%)
    • medial hyperplasia (8-10%)
  • adventitia: rare 
    • adventitial fibroplasia (1%) 8

The outcome is arterial stenoses. Fibromuscular dysplasia most commonly causes small stenoses along a vessel with intervening areas of dilatation (small aneurysms), creating a “string of beads” appearance. Less commonly the stenosis has a smooth tapered appearance. Fibromuscular dysplasia also weakens the vessel wall which predisposes to dissection.

Location

Fibromuscular dysplasia may affect any medium sized artery in the body, and is commonly multifocal and bilateral (up to 60% when involving the renal arteries). Fibromuscular dysplasia usually involves mid segment of the vessels and spares origins. Some sites are more frequently involved 9:

Complications

Radiographic features

Arterial imaging with CT angiography, MR angiography and digital subtraction angiography (DSA) may be used to visualise the lesions in fibromuscular dysplasia. 

Selective DSA is the gold standard because it allows visualisation of small or peripheral lesions. The characteristic finding, particularly in the more common medial subtype, is alternating stenoses and dilatations, causing a string of beads appearance 5

Less commonly in intimal and adventitial types, there is focal concentric, long-segment tubular stenosis or diverticular outpouching present (see carotid intimal fibromuscular dysplasia). Cross-sectional imaging (CT and MRI) allows assessment of end-organ ischaemic damage.

  • typical angiographic features include: vascular loops, fusiform vascular ectasia and a string of beads
  • less typical features include: arterial dissection, aneurysm and subarachnoid haemorrhage

Treatment and prognosis

Asymptomatic cases are only observed but if symptomatic then fibromuscular dysplasia responds well to angioplasty, with high long-term patency rates. A stent is generally not required.  

History and etymology

The first case of fibromuscular dysplasia initially described by Leadbetter and Burkland  in 1938 while the first case of histologically proven carotid fibromuscular dysplasia was published by M C Connett and J M Lansche in 1965 7

Differential diagnosis

Imaging differential considerations include:

  • -<li>iliac arteries</li>
  • +<li><a href="/articles/iliac-arteries">iliac arteries</a></li>
  • -<a href="/articles/coeliac-artery">coeliac trunk</a> and mesenteric arteries</li>
  • +<a href="/articles/coeliac-artery">coeliac trunk</a> and <a href="/articles/mesenteric-arteries">mesenteric arteries</a>
  • +</li>
  • -</ul><h4>Treatment and prognosis</h4><p>Asymptomatic cases are only observed but if symptomatic then fibromuscular dysplasia responds well to angioplasty, with high long-term patency rates. A stent is generally not required.  </p><h4>Differential diagnosis</h4><p>Imaging differential considerations include:</p><ul>
  • +</ul><h4>Treatment and prognosis</h4><p>Asymptomatic cases are only observed but if symptomatic then fibromuscular dysplasia responds well to angioplasty, with high long-term patency rates. A stent is generally not required.  </p><h4>History and etymology</h4><p>The first case of fibromuscular dysplasia initially described by <strong>Leadbetter</strong> and <strong>Burkland </strong> in 1938 while the first case of histologically proven <em>carotid</em> fibromuscular dysplasia was published by <strong>M C Connett </strong>and <strong>J M Lansche</strong> in 1965 <sup>7</sup></p><h4>Differential diagnosis</h4><p>Imaging differential considerations include:</p><ul>

References changed:

  • 14. Connett M & Lansche J. Fibromuscular Hyperplasia of the Internal Carotid Artery: Report of a Case. Ann Surg. 1965;162(1):59-62. <a href="https://doi.org/10.1097/00000658-196507000-00010">doi:10.1097/00000658-196507000-00010</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/14308796">Pubmed</a>
  • 15. Furie D & Tien R. Fibromuscular Dysplasia of Arteries of the Head and Neck: Imaging Findings. AJR Am J Roentgenol. 1994;162(5):1205-9. <a href="https://doi.org/10.2214/ajr.162.5.8166011">doi:10.2214/ajr.162.5.8166011</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/8166011">Pubmed</a>
  • 16. Persu A, Touzé E, Mousseaux E, Barral X, Joffre F, Plouin P. Diagnosis and Management of Fibromuscular Dysplasia: An Expert Consensus. Eur J Clin Invest. 2011;42(3):338-47. <a href="https://doi.org/10.1111/j.1365-2362.2011.02577.x">doi:10.1111/j.1365-2362.2011.02577.x</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/21854373">Pubmed</a>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.